2014
DOI: 10.1134/s0012496614040139
|View full text |Cite
|
Sign up to set email alerts
|

Exogenous protein HSP70 blocks neurodegeneration in the rat model of the clinical stage of Parkinson’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 11 publications
0
7
0
Order By: Relevance
“…8B). All but one of these hubs have been implicated in PD: AKT1 (37 edges) 70,71 , HGS (26 edges), CDC37/HSP90 (22 edges) 72,73 , STUB1/CHIP (20 edges) 74 , and HSPA1A (22 edges) 7577 (Fig. 7B).…”
Section: Resultsmentioning
confidence: 99%
“…8B). All but one of these hubs have been implicated in PD: AKT1 (37 edges) 70,71 , HGS (26 edges), CDC37/HSP90 (22 edges) 72,73 , STUB1/CHIP (20 edges) 74 , and HSPA1A (22 edges) 7577 (Fig. 7B).…”
Section: Resultsmentioning
confidence: 99%
“…In addition, it has been demonstrated that mutation in these genes also relate to onset of manganism [1820]. As a putative treatment, recently, studies provided evidence on the important role of HSP70 in recovering DAergic neurons or degrading misfolded proteins in PD models [21, 22]. …”
Section: Introductionmentioning
confidence: 99%
“…HSP70-related anti-fibrillation may have contributed to the protection of dopaminergic neurons in MANF-treated cells and PD animals [28]. Earlier studies have shown that the aggregation ofα-Synuclein is linked to the pathogenesis of PD.…”
Section: Discussionmentioning
confidence: 99%